Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer (Q46120245)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 June 2013
edit
Language Label Description Also known as
English
Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
scientific article published on 20 June 2013

    Statements

    Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit